利妥昔单抗与低剂量霉酚酸酯治疗儿童和青年成人激素依赖型肾病综合征复发的随机临床试验
Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial.
作者信息
Ravani Pietro, Lugani Francesca, Drovandi Stefania, Caridi Gianluca, Angeletti Andrea, Ghiggeri Gian Marco
机构信息
Division of Nephrology, University of Calgary, Calgary, Alberta, Canada.
Division of Nephrology, Dialysis and Transplantation, Istituto Giannina Gaslini IRCCS, Genoa, Italy.
出版信息
JAMA Pediatr. 2021 Jun 1;175(6):631-632. doi: 10.1001/jamapediatrics.2020.6150.
Abstract
This randomized clinical trial examines the superiority of a single dose of rituximab vs low-dose mycophenolate mofetil in preventing the recurrence of steroid-dependent nephrotic syndrome in children and young adults.
摘要
这项随机临床试验旨在检验单剂量利妥昔单抗与低剂量霉酚酸酯在预防儿童和青年类固醇依赖型肾病综合征复发方面的优越性。
相似文献
1
Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial.利妥昔单抗与低剂量霉酚酸酯治疗儿童和青年成人激素依赖型肾病综合征复发的随机临床试验
JAMA Pediatr. 2021 Jun 1;175(6):631-632. doi: 10.1001/jamapediatrics.2020.6150.
2
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).研究方案：吗替麦考酚酯作为利妥昔单抗治疗儿童起病、复杂、频繁复发型肾病综合征或激素依赖型肾病综合征后的维持治疗：一项多中心、双盲、随机、安慰剂对照试验（JSKDC07）。
BMC Nephrol. 2018 Nov 1;19(1):302. doi: 10.1186/s12882-018-1099-7.
3
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.随机临床试验比较重复利妥昔单抗疗程与单次利妥昔单抗疗程后序贯霉酚酸酯维持治疗在儿童激素依赖性肾病综合征中的疗效和安全性。
BMC Nephrol. 2020 Nov 30;21(1):520. doi: 10.1186/s12882-020-02153-5.
4
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.霉酚酸酯在利妥昔单抗治疗儿童起病的复杂频复发或激素依赖型肾病综合征后的应用。
J Am Soc Nephrol. 2022 Feb;33(2):401-419. doi: 10.1681/ASN.2021050643. Epub 2021 Dec 8.
5
Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.霉酚酸酯在对利妥昔单抗成功应答后的缓解维持中的作用。
Pediatr Nephrol. 2009 Feb;24(2):423-4. doi: 10.1007/s00467-008-1030-8. Epub 2008 Oct 14.
6
Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.霉酚酸酯或他克莫司用于对类固醇敏感但频繁复发或依赖类固醇的儿童肾病综合征的评估。
Nephrology (Carlton). 2016 Jan;21(1):21-7. doi: 10.1111/nep.12537.
7
Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.利妥昔单抗治疗后霉酚酸酯用于儿童激素抵抗型肾病综合征的研究
Pediatrics. 2015 Jul;136(1):e132-9. doi: 10.1542/peds.2015-0486.
8
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.利妥昔单抗治疗儿童激素和钙调磷酸酶抑制剂依赖型肾病综合征的短期疗效：一项随机对照试验。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1308-15. doi: 10.2215/CJN.09421010. Epub 2011 May 12.
9
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.利妥昔单抗治疗后激素依赖型肾病综合征患儿复发及长期预后的预测因素
Clin Exp Nephrol. 2017 Aug;21(4):671-676. doi: 10.1007/s10157-016-1328-y. Epub 2016 Aug 24.
10
Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.霉酚酸在激素依赖型特发性肾病综合征儿童中的药代动力学及复发情况
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1777-1782. doi: 10.2215/CJN.00320116. Epub 2016 Jul 21.
引用本文的文献
1
Clinical practice guidelines for rituximab treatment in children with steroid-sensitive nephrotic syndrome.儿童激素敏感型肾病综合征利妥昔单抗治疗的临床实践指南
World J Pediatr. 2025 Aug 13. doi: 10.1007/s12519-025-00957-9.
2
Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022.2010年至2022年抗CD20抗体在儿童肾病综合征治疗中的应用
Pediatr Nephrol. 2025 Jun 5. doi: 10.1007/s00467-025-06811-4.
3
Anti-CD20 monoclonal antibodies for idiopathic nephrotic syndrome: Advances, challenges, and future directions.用于特发性肾病综合征的抗CD20单克隆抗体：进展、挑战及未来方向
Pediatr Nephrol. 2025 May 1. doi: 10.1007/s00467-025-06738-w.
4
The efficacy and dynamic changes of immune function of rituximab with mycophenolate mofetil in the treatment of steroid-dependent /frequently relapsing nephrotic syndrome: a retrospective follow-up study.利妥昔单抗联合霉酚酸酯治疗激素依赖/频繁复发型肾病综合征的疗效及免疫功能动态变化：一项回顾性随访研究
BMC Nephrol. 2025 Apr 10;26(1):186. doi: 10.1186/s12882-025-04093-4.
5
Single (375 mg/m) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial.单剂量（375毫克/平方米）与双倍剂量利妥昔单抗联合霉酚酸酯治疗激素依赖型/频繁复发型肾病综合征儿童：一项多中心开放标签随机对照试验。
Pediatr Nephrol. 2025 Apr;40(4):995-1004. doi: 10.1007/s00467-024-06619-8. Epub 2024 Dec 27.
6
Long Term Evaluations of First Single-dose Rituximab in Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome.长期评估首剂利妥昔单抗治疗儿童激素依赖型微小病变肾病综合征。
Ren Fail. 2024 Dec;46(2):2427173. doi: 10.1080/0886022X.2024.2427173. Epub 2024 Nov 26.
7
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.儿童类固醇敏感型肾病综合征的非皮质类固醇类免疫抑制药物。
Cochrane Database Syst Rev. 2024 Nov 8;11(11):CD002290. doi: 10.1002/14651858.CD002290.pub6.
8
Preventing Relapses in Childhood Nephrotic Syndrome.预防儿童肾病综合征的复发
Kidney Int Rep. 2024 Mar 13;9(5):1149-1151. doi: 10.1016/j.ekir.2024.03.017. eCollection 2024 May.
9
Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis.儿童频繁复发/依赖类固醇的肾病综合征的免疫抑制剂：一项系统评价和网状Meta分析
Front Immunol. 2024 Feb 23;15:1310032. doi: 10.3389/fimmu.2024.1310032. eCollection 2024.
10
Retrospective Cross-Sectional Study Reviewing the Effectiveness of Mycophenolate Mofetil on Saudi Children With Nephrotic Syndrome.回顾性横断面研究：评估霉酚酸酯对沙特肾病综合征儿童的疗效
Cureus. 2023 Nov 29;15(11):e49679. doi: 10.7759/cureus.49679. eCollection 2023 Nov.
Zotero 插件